Steve Jobs' Resignation Not Indicative of Sudden Worsening of Health
Steve Jobs had been on medical leave for 7 months when he resigned as CEO today, saying in a letter that he would be the first to admit it "if there ever came a day when I could no longer meet my duties and expectations as Apple’s CEO. Unfortunately, that day has come."
In his article about the resignation, Adam Satariano writes for Bloomberg about Jobs' recent health and his activities today. Most importantly, he notes that the resignation was not in response to a sudden change in Jobs' health:
The day of the announcement, Jobs was in Apple’s Cupertino, California, office for the entire work day, and he attended a regularly scheduled board meeting, according to a person close to Jobs, who was not authorized to speak about the executive’s health. While Jobs has been housebound for the past few weeks and his condition is weak, the resignation was not indicative of a sudden worsening, this person said.
Jobs has been dealing with complications following treatment of a rare form of pancreatic cancer since 2004 and a liver transplant in 2009.
The North Carolina Utilities Commission today officially approved (PDF) Apple's proposal to construct a 4.8-megawatt fuel cell electric generating facility near its data center in Maiden, North...
In the week since Apple's last developer update of OS X Mountain Lion, several new features including hints of automatic app downloads have been discovered in the next-generation operating...
BGR reports that Microsoft is planning to launch Office for iOS in November this year, with the source claiming first-hand knowledge of the software running on an iPad. With the app's splash...
The Palo Alto Online has unearthed plans for a new glass-enclosed retail store going in near the current Stanford mini-store at the Stanford Shopping Center in Palo Alto, CA.
The store will have...
Earlier this week, Apple CEO Tim Cook met with his counterpart from Samsung, Choi Gee-sung, as part of court-mediated talks seeking to find common ground in the ongoing patent battles between the two...